2 Top Picks From “The Rest Of The Biopharma Industry”
While most of the attention in the biotech space is currently focused on companies working on potential vaccines for the novel coronavirus and treatments for…
Zenect Wealth
Why The Biotech With The First Testable COVID-19 Vaccine Is A “Pronto” Sell
This biotech firm has the first testable vaccine for the novel coronavirus, but the author of today’s article argues that “If you’re looking for massive…
As The COVID-19 Vaccine Competition Heats Up, Consider These Biotech Stocks & ETFs
As the number of those infected with COVID-19 goes up domestically and globally, the competition to develop a vaccine is heating up – and the…
Life-Saving Biotechs Offering “Life-Changing Gains”
No matter what happens to the economy, people aren’t going to stop taking their prescription medications. As a result, the author of today’s article suggests…
The Coronavirus Stimulus Bill Could Stimulate These Beaten-Down Stocks
While some are clearly being hit harder than others, every sector is being impacted to some extent by the widespread disruptions caused by the coronavirus…
More Upside Ahead For This Fallen Advertising Stock?
While the stock highlighted in today’s article is, like most, down significantly this year, it has risen in recent days – and one trader believes…
“What The Hell Is Going On?”
In recent days, the stock market has experienced both its worst – and best – days in decades, leading the author of today’s article to…
The Most Efficient Way To Play Oil’s Eventual Rebound
While the authors of today’s article are stock pickers, they argue that there are some situations where exchange-traded funds are the better option – and…
‘Indiscriminate Selling’ Has Made These Quality Stocks A Practical ‘Steal’
The “indiscriminate selling” that has taken place over the past month has created an opportunity for investors to “practically steal” a large number of quality…
As The Market Plunges, Consider These ETFs
When it comes to the violent swings experienced by the stock market over the last few weeks, the author of today’s article points out that…